|

Rosuvastatin 10 mg tablet. Clinical Trials

3 actively recruiting trials across 2 locations

Pipeline

Phase 1: 1Phase 3: 2

Top Sponsors

  • PMV Pharmaceuticals, Inc1
  • Ain Shams University1
  • Advenchen Laboratories, LLC1

Indications

  • Cancer2
  • TP53 Y220C Mutation1
  • Major Depressive Disorder1
  • MDD1
  • Alveolar Soft Part Sarcoma1

Other1 trial

Efficacy of Statins Among Major Depressive Disorder
Phase 3

Phoenix, Arizona1 trial

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

Mayo Clinic Arizona

Phase 3

Denver, Colorado1 trial

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

HealthOne Denver

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.